BIOSECURE Act Diluted Significantly, But China Plus Strategy Still Accelerating: Strides MD

Significant growth expected in H2 FY25

 
• By Vibha Ravi
  
Simmering US-China Tensions Are Leading To Business Rebalancing
Simmering US-China Relations Necessitate Business Rebalancing • Source: Shutterstiock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip